Publications
47
Citations
268
Est. group size
~1
Recurring co-author estimate
Active years
18
Publishing since 2008
Kristen A. Russ conducts research on blood-based biomarkers for Alzheimer's disease and related dementias, studying how measurable proteins in plasma (such as pTau217, GFAP, and amyloid ratios) relate to cognitive decline, brain imaging, and neuropathology. Much of this work involves large community cohorts and shared research resources like biomarker repositories, and includes comparisons of laboratory measurement methods. Some projects also extend to cognitive risk across diverse populations and unrelated topics such as radiation effects and music therapy for children with cancer.
Publication activity has grown over the past several years, rising from a few papers annually to roughly six per year on average recently, with the highest output in 2025.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Typically publishes in teams of ~10 · 0% small-team papers (≤3 authors) · across 12 venues
- Data Sharing Models for the National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)
Alzheimer s & Dementia · 2025
- Assessing Cognitive Decline and Dementia Risk in Black and White Older Adults with Blood Biomarkers pTau217, GFAP, NfL, and Aβ ratio
medRxiv · 2025
- Neuropathologic correlates of distinct plasma biomarker profiles in community-living older adults
Brain · 2025
- NCRAD: A Critical Resource for the Alzheimer's Disease and Related Dementias Research Community
Alzheimer s & Dementia · 2025
- The National Centralized Repository for Alzheimer's Disease and Related Dementia's Biomarker Assay Laboratory: A Resource for the Alzheimer's Disease Research Community
Alzheimer s & Dementia · 2025
- Association of Retinal Perfusion with Plasma Biomarkers of Alzheimer's Disease
Alzheimer s & Dementia · 2025
- Integration of plasma and imaging data within the ADRC biofluid and imaging ecosystems
Alzheimer s & Dementia · 2025
- Cross‐Sectional Analysis of Plasma GFAP Across Alzheimer's Disease Stages
Alzheimer s & Dementia · 2025
- Assessing Cognitive Decline and Dementia Risk in Black and White Older Adults With Blood Biomarkers pTau217, GFAP, NfL, and Aβ Ratio
Neurology · 2025
- Alzheimer’s Disease Plasma Biomarker Results from across 14 Alzheimer’s Disease Research Centers
Alzheimer s & Dementia · 2024
- Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non‐genetic risk factors for Alzheimer's disease among Asian Americans and Canadians
Alzheimer s & Dementia · 2024
- Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health‐related comorbidities in a community‐dwelling cohort
Alzheimer s & Dementia · 2024
- Survey of Changes in Absolute Lymphocyte Counts and Peripheral Immune Repertoire Diversity after External Beam Radiotherapy
Radiation Research · 2024
- Associations among plasma, MRI and amyloid PET biomarkers of dementia and the impact of health‐related comorbidities
Alzheimer s & Dementia · 2023
- Comparison of plasma Ab42, Ab40, and p‐tau181 assessed on two different platforms with CSF AD biomarkers and amyloid (PiB) PET
Alzheimer s & Dementia · 2023
- Alzheimer s & Dementia×22
- Toxicology and Applied Pharmacology×5
- The FASEB Journal×3
- Brain×1
- Inhalation Toxicology×1
- Andrew J. Saykin
Medicine · Indiana University
- Angelina J. Polsinelli
Medicine · Indiana University
- Alexander N. Hasselbach
Medicine · The Ohio State University
- Anahita Adeli
Medicine · The Ohio State University
- Ann J. Lee
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 27, 2026.
Claim or correct this profile